Cornerstone Planning Group LLC Bristol Myers Squibb CO Transaction History
Cornerstone Planning Group LLC
- $407 Billion
- Q4 2024
A detailed history of Cornerstone Planning Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 787 shares of BMY stock, worth $48,408. This represents 0.01% of its overall portfolio holdings.
Number of Shares
787
Previous 655
20.15%
Holding current value
$48,408
Previous $34.4 Million
38.7%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,762Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.76 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.91 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.85 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.71 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $131B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...